Ropivacaine
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Bunion
Conditions
Bunion
Trial Timeline
Mar 13, 2023 → Aug 30, 2024
NCT ID
NCT05773846About Ropivacaine
Ropivacaine is a phase 3 stage product being developed by PainReform for Bunion. The current trial status is completed. This product is registered under clinical trial identifier NCT05773846. Target conditions include Bunion.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05773846 | Phase 3 | Completed |
Competing Products
2 competing products in Bunion
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| CG5503 IR + Morphine + Placebo | Johnson & Johnson | Phase 3 | 77 |
| HTX-034 + HTX-034 + Bupivacaine HCl | Heron Therapeutics | Phase 1/2 | 33 |